Mechanical clot disruption following intravenous recombinant tissue plasminogen activator administration in non-responders

Neurologia Medico-Chirurgica

Volumn 50, Issue 3, 2010, Pages 183-190

  Kawakami, Taichiro ^a   Terakawa, Yuzo ^a   Tsuruno, Takashi ^b   Murata, Takaho ^b   Nishio, Akimasa ^a   Ohata, Kenji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Neurosurgery   (Japan)

Author keywords

Angioplasty; Mechanical clot disruption; Percutaneous transluminal angioplasty; Stroke; Tissue plasminogen activator

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; MECHANICAL THROMBECTOMY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANKIN SCALE; RECANALIZATION; SINGLE DRUG DOSE;

EID: 77950428321     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.50.183     Document Type: Article

References (33)

1. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 103: 2897-2902, 2001
2. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 31: 610-614, 2000
3. Anonymous: The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 312: 932-936, 1985
4. Anonymous: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333: 1581-1587, 1995
5. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC: Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. Stroke 31: 1812-1816, 2000
6. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS: Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 38: 1274-1280, 2007
7. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: 66-73, 2005
8. Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM: Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke. Stroke 33: 279-282, 2002
9. Imai K, Mori T, Izumoto H, Watanabe M: Successful thrombectomy in acute terminal internal carotid occlusion using a basket type microsnare in conjunction with temporary proximal occlusion: a case report. AJNR Am J Neuroradiol 26: 1395-1398, 2005
10. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35: 904-911, 2004
11. IMS II Trial Investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 38: 2127-2135, 2007
12. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K: Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 16: 1977-1986, 1995
13. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, Ojemann RG: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54: 773-782, 1981
14. Kim DJ, Kim DI, Kim SH, Lee KY, Heo JH, Han SW: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 47: 616-621, 2005
15. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 34: 695-698, 2003
16. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH: Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by preand postthrombolytic angiography in acute ischemic stroke patients. Stroke 38: 192-193, 2007
17. Lee KY, Kim DI, Kim SH, Lee SI, Chung HW, Shim YW, Kim SM, Heo JH: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 25: 1470-1475, 2004
18. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 33: 2872-2876, 2002
19. Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, Song JK, Grotta JC, Campbell MS 3rd: Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 36: 292-296, 2005
20. Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z, Yahia AM, Lopes DK, Boulos AS, Ringer AJ, Saad M, Guterman LR, Hopkins LN: Aggressive mechanical clot disruption and low-dose intra-arterial thirdgeneration thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 51: 1319-1329, 2002
21. Ribo M, Molina CA, Rovira A, Quintana M, Delgado P, Montaner J, Grive E, Arenillas JF, Alvarez-Sabin J: Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 36: 602-606, 2005
22. Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN: Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 48: 1282-1290, 2001
23. Schellinger PD, Fiebach JB, Hacke W: Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34: 575-583, 2003
24. Sekoranja L, Loulidi J, Yilmaz H, Lovblad K, Temperli P, Comelli M, Sztajzel RF: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study. Stroke 37: 1805-1809, 2006
25. Smith WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 27: 1177-1182, 2006
26. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39: 1205-1212, 2008
27. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36: 1432-1438, 2005
28. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50: 251-260, 2002
29. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S: Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 29: 2568-2574, 1998
30. Wunderlich MT, Goertler M, Postert T, Schmitt E, Seidel G, Gahn G, Samii C, Stolz E: Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology 68: 1364-1368, 2007
31. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37: 1810-1815, 2006
32. Yoon W, Seo JJ, Kim JK, Cho KH, Park JG, Kang HK: Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke 35: 876-881, 2004
33. Zaidat OO, Suarez JI, Sunshine JL, Tarr RW, Alexander MJ, Smith TP, Enterline DS, Selman WR, Landis DM: Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 26: 880-884, 2005